ArticleCurrent oncology (Toronto, Ont.)2026
Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3-6 Month Relapse Window.
İbrahim Çil, Maral Martin Mıldanoğlu, Yasin Kutlu, Ali Kaan Güren, Murat Sarı, İlker Nihat Ökten, Fatih Atalah, Tuba Baydaş, Cevat İlteriş Kıkılı, Deniz Tural and 12 more
Abstract readControlled Clinical TrialMulticenter Study
In one paragraphArticle in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
22 authors.
İbrahim ÇilDepartment of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul 34764, Türkiye.ORCID 0000-0002-6388-0346 Maral Martin MıldanoğluDepartment of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34214, Türkiye.ORCID 0000-0002-4587-0726 Yasin KutluDepartment of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34214, Türkiye.ORCID 0000-0003-2184-634X Ali Kaan GürenDepartment of Medical Oncology, School of Medicine, Marmara University, Istanbul 34899, Türkiye.ORCID 0000-0002-3562-5006 Murat SarıDepartment of Medical Oncology, School of Medicine, Marmara University, Istanbul 34899, Türkiye.ORCID 0000-0003-0596-1559 İlker Nihat ÖktenDepartment of Medical Oncology, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul 34722, Türkiye.ORCID 0000-0003-2360-3392 Fatih AtalahDepartment of Medical Oncology, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul 34722, Türkiye.ORCID 0000-0002-5664-7853 Tuba BaydaşDepartment of Medical Oncology, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul 34722, Türkiye.ORCID 0000-0001-7336-4647 Cevat İlteriş KıkılıDepartment of Medical Oncology, School of Medicine, Koç University, Istanbul 34010, Türkiye.
Deniz TuralDepartment of Medical Oncology, School of Medicine, Koç University, Istanbul 34010, Türkiye.
Ayberk BayramgilDepartment of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul 34764, Türkiye.ORCID 0000-0003-1782-7808 Gözde Balkaya AykutDepartment of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul 34764, Türkiye.
Pembegül YumuştutanDepartment of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul 34764, Türkiye.
Eda ErçinDepartment of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul 34764, Türkiye.ORCID 0009-0002-1300-8944 Bekir DoğanDepartment of Medical Oncology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul 34147, Türkiye.
Mesut YılmazDepartment of Medical Oncology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul 34147, Türkiye.ORCID 0000-0003-1466-3887 Özgür HanDepartment of Medical Oncology, Istanbul Training and Research Hospital, Istanbul 34098, Türkiye.ORCID 0000-0003-4223-4940 Bünyamin GüneyDepartment of Medical Oncology, Istanbul Training and Research Hospital, Istanbul 34098, Türkiye.ORCID 0009-0005-5721-9550 Sercan OlcarDepartment of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0009-0002-0602-4778 Hatice OdabaşDepartment of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0000-0002-5757-4705 Ahmet BiliciDepartment of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34214, Türkiye.ORCID 0000-0002-0443-6966 Melike ÖzçelikDepartment of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul 34764, Türkiye.ORCID 0000-0003-0406-715X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antineoplastic Combined Chemotherapy ProtocolsLung NeoplasmsNeoplasm Recurrence, LocalPlatinumSmall Cell Lung CarcinomaAgedFemaleHumansMaleMiddle AgedRetrospective StudiesPlatinumplatinum-free intervalplatinum rechallengesecond-line chemotherapysmall-cell lung cancer
Identifiers
PMID42645377
PMCPMC13511104
What OpenQuestion holds
Textmetadata
Read underepoch 390